Myofascial Pain Syndrome Treatment: Trigger Points, Therapy and Injections
A clinician-reviewed guide to myofascial pain syndrome treatment: how trigger points are identified, which physical therapies and medications have evidence, when dry needling or trigger point injections help, and how it differs from fibromyalgia.
Analyzed Article
This fact-check analysis pertains to a specific external article.
Title: Muscle Disorders ( Read original article )
Source: National Library of Medicine
Claim-by-Claim Ledger
| ID | Claim | Risk | Verdict | Evidence | Notes |
|---|---|---|---|---|---|
| C1 | Myofascial pain syndrome is diagnosed clinically by finding a taut band with a tender trigger point that reproduces referred pain, not by imaging or blood tests. | medium | supported | V1 | StatPearls states myofascial pain syndrome is primarily a clinical diagnosis; palpation reveals taut bands, and compression can elicit local pain, a local twitch response or referred pain. There are no standardized laboratory or imaging criteria. |
| C2 | Reported prevalence of myofascial pain syndrome ranges from 30% to 93% of patients seeking care for musculoskeletal pain. | low | supported | V1 | StatPearls reports this range and attributes the wide spread to the absence of standardized diagnostic criteria; the true general-population prevalence is unknown. |
| C3 | Dry needling and local anesthetic trigger point injection both reduce myofascial pain, and neither is clearly superior to the other. | medium | supported | V1, V2 | Systematic reviews cited in StatPearls confirm therapeutic effects for both dry needling and local anesthetic injection; head-to-head superiority is not established. |
| C4 | NSAIDs are the most commonly prescribed drug for myofascial pain syndrome despite a lack of randomized trials in this condition. | medium | partial | V1 | StatPearls notes NSAIDs are the most prescribed analgesic but that RCT evidence specifically in myofascial pain syndrome is lacking; benefit is extrapolated from acute musculoskeletal pain. |
| C5 | Myofascial pain syndrome is distinguished from fibromyalgia by localised taut bands with referred pain rather than widespread diffuse tenderness. | medium | supported | V1, V3, S3 | StatPearls describes fibromyalgia as diffuse tender points without taut bands or referred pain, usually with comorbid insomnia, low mood and numbness that are rare in myofascial pain syndrome. |
Myofascial pain syndrome treatment works best as a package: release the trigger point, restore the muscle’s length and strength, and correct whatever caused the overload in the first place. Trigger point release can be manual pressure, dry needling or a local anesthetic injection, and evidence supports all three. Medication plays a supporting role only. Without fixing posture, ergonomics or an underlying structural problem, the pain typically returns [V1].
Key numbers
- Reported prevalence: 30% to 93% of people seeking care for musculoskeletal pain, depending on the study and criteria used [V1].
- Most commonly affected regions: neck, shoulders and back [V1].
- Typical age range: 27 to 50 years, though sedentary adults, athletes and manual workers of any age are affected [V1].
- Chronic form: pain lasting 6 months or longer; average symptom duration in one cited study was 63 months (range 6 to 180 months) [V1].
- Trigger point injection volume: usually 0.2 to 1 mL of solution per point [V2].
What myofascial pain syndrome actually is
Myofascial pain syndrome is regional muscle pain generated by trigger points: hyperirritable spots inside a palpable taut band of muscle fibres. Pressing an active trigger point reproduces the patient’s familiar pain, often in a referred pattern some distance away, and may produce a local twitch response [V1].
The cause is not fully understood, but muscle overload from overuse or disuse is the leading explanation. Recognised risk factors include muscle trauma, ergonomic strain and poor posture, structural issues such as spondylosis, scoliosis and osteoarthritis, and systemic contributors including hypothyroidism, vitamin D deficiency and iron deficiency [V1].
How it is diagnosed
Diagnosis is clinical. There is no blood test or scan that confirms myofascial pain syndrome; imaging is used to rule out other causes rather than to make the diagnosis [V1][S1].
A clinician palpates the painful region looking for a taut band, a discrete tender nodule within it, reproduction of the patient’s usual pain on compression, and referred pain or a twitch response. Reduced range of motion, muscle stiffness and disturbed sleep are common companions. Conditions that mimic it — tendinopathy, arthritis, bursitis and nerve entrapment — need to be excluded by history and examination [V1].
Myofascial pain syndrome vs fibromyalgia
| Feature | Myofascial pain syndrome | Fibromyalgia |
|---|---|---|
| Pain distribution | Regional, one or a few muscles | Widespread, both sides, above and below the waist |
| Examination finding | Taut band with a discrete trigger point | Diffuse tender points, no taut bands |
| Referred pain | Characteristic referral patterns | Not a defining feature |
| Typical companions | Local stiffness, reduced range of motion | Fatigue, insomnia, cognitive fog, low mood |
| First-line treatment | Trigger point release plus exercise and ergonomics | Graded aerobic exercise, sleep and mood management, centrally acting medication |
Patients with multiple chronic trigger points should be assessed for fibromyalgia, and the two can coexist [V1][V3][S3]. Our fibromyalgia treatment guide covers the widespread-pain pathway in detail.
Physical and non-drug treatment
Every patient should be taught stretching and ergonomic modification — this is the part that prevents recurrence [V1].
Beyond that, the evidence StatPearls summarises is as follows. Extracorporeal shockwave therapy and low-power laser therapy significantly reduce pain in multiple studies. Manual therapy, including ischemic compression of the trigger point, improves pain tolerance. Transcutaneous electrical nerve stimulation (TENS) gives short-term relief but has not shown lasting benefit. Therapeutic ultrasound is widely used but the evidence remains inconclusive [V1].
Medication: a supporting role
NSAIDs are the most commonly prescribed drug for myofascial pain, yet there are no randomized controlled trials specifically in this condition; benefit is inferred from acute musculoskeletal pain, and long-term use carries gastrointestinal, kidney and bleeding risks [V1].
Muscle relaxants are used as an adjunct when spasm is prominent or NSAIDs alone fall short. Topical lidocaine patches have supportive randomized evidence. Gabapentin and pregabalin may be considered but have not been tested in myofascial pain syndrome trials. Tricyclics and SNRIs help where sleep disturbance and mood are part of the picture. Opioids are generally not indicated and may be counterproductive [V1][S2]. See our chronic pain management guide for how these classes fit together.
Dry needling and trigger point injections
When conservative care stalls, needling the trigger point directly is the next step. Dry needling uses a fine needle with no medication; trigger point injection delivers a small volume — typically 0.2 to 1 mL — of local anesthetic into the point after the skin is cleaned and the needle aspirated to confirm it is not in a vessel [V2].
Systematic reviews confirm therapeutic effects for both dry needling and local anesthetic injection, and neither has been shown clearly superior [V1][V2]. Post-needling soreness for one to two days is normal. Injections are most useful when they open a window for the stretching and strengthening work that produces durable change; read what to expect from trigger point injections before booking one. Neck-dominant cases overlap heavily with the approaches in our neck pain treatment guide.
Red flags: when to see a doctor promptly
Muscle pain is usually benign, but seek medical assessment without delay if you have any of the following [V1][S1][S2]:
- Progressive weakness, numbness, or loss of bladder or bowel control
- Fever, night sweats, or unexplained weight loss with the muscle pain
- Pain following significant trauma, or a sudden severe tearing sensation
- Dark or cola-coloured urine after intense exertion (possible rhabdomyolysis)
- A hot, swollen, red area of muscle, or a rapidly enlarging lump
- Pain that wakes you every night, or that is steadily worsening despite four to six weeks of appropriate treatment
What a realistic treatment plan looks like
Weeks 0-2: identify and remove the precipitant (workstation, sleep position, training load), begin heat and daily stretching, consider a short NSAID or topical lidocaine course. Weeks 2-6: add supervised manual therapy or physiotherapy with progressive strengthening; screen for systemic contributors such as thyroid, vitamin D or iron deficiency. Weeks 6-12: if trigger points persist, add dry needling or trigger point injection, paired with continued exercise. Beyond 12 weeks: reassess the diagnosis, screen for fibromyalgia, and address sleep and mood, which strongly influence chronic pain outcomes [V1][V3][S2].
Frequently asked questions
What is the most effective treatment for myofascial pain syndrome?
No single treatment wins for everyone. The strongest approach combines trigger point release (manual therapy, dry needling or local anesthetic injection) with stretching, a graded exercise programme and correction of the cause, such as posture, workstation setup or an underlying spine problem. Treating the trigger point without fixing the precipitating factor invites relapse [V1].
How long does myofascial pain syndrome last?
Acute myofascial pain often settles within weeks with heat, stretching, manual therapy or a single needling treatment. The chronic form persists six months or longer; in one study cited by StatPearls the average symptom duration was 63 months, with a range of 6 to 180 months. Longer duration predicts a slower, more stubborn recovery [V1].
Is myofascial pain syndrome the same as fibromyalgia?
No. Myofascial pain syndrome is regional: a taut band in one or a few muscles with a tender trigger point that refers pain in a predictable pattern. Fibromyalgia is widespread pain with diffuse tenderness, no taut bands, and usually insomnia, fatigue and low mood. Careful palpation of the painful area is what separates them [V1][V3][S3].
Does dry needling hurt, and is it better than injection?
Dry needling usually causes a brief deep ache or a local twitch of the muscle, then soreness for one to two days. Systematic reviews show dry needling and local anesthetic trigger point injection both reduce pain, and neither is clearly better. Injections may be more comfortable afterwards because the anesthetic dulls post-needling soreness [V1][V2].
Which muscles are most often affected by trigger points?
The neck, shoulder girdle and back are the most frequently affected regions. Common culprits include the upper trapezius, levator scapulae, infraspinatus, quadratus lumborum and gluteal muscles. Referred pain patterns are typical: an infraspinatus trigger point, for example, commonly refers pain to the front of the shoulder and down the arm [V1].
References
- [V1] Tantanatip A, Patisumpitawong W, Chang KV. Myofascial Pain Syndrome. StatPearls, NCBI Bookshelf. 2024. Source . Accessed 2026-08-21.
- [V2] Wong CSM, Wong SHS, et al.. Trigger Point Injection. StatPearls, NCBI Bookshelf. 2023. Source . Accessed 2026-08-21.
- [V3] Bhargava J, Hurley JA. Fibromyalgia. StatPearls, NCBI Bookshelf. 2024. Source . Accessed 2026-08-21.
- [S1] National Library of Medicine. Muscle Disorders. MedlinePlus. 2025. Source . Accessed 2026-08-21.
- [S2] National Library of Medicine. Chronic Pain. MedlinePlus. 2025. Source . Accessed 2026-08-21.
- [S3] National Institute of Arthritis and Musculoskeletal and Skin Diseases. Fibromyalgia. NIH NIAMS. 2025. Source . Accessed 2026-08-21.
Editorial Notes
Educational review only. This content is not personalized medical advice, diagnosis, or treatment. Consult a licensed clinician about your own care.
Explore More In This Topic
Looking for additional coverage in this category? Browse all Musculoskeletal Pain fact checks.